Abstract
During mammalian energy homeostasis, the glucagon receptor (Gcgr) plays a key role in regulating both glucose and lipid metabolisms. However, the mechanisms by which these distinct signaling arms are differ-entially regulated remain poorly understood. Using a Cy5-glucagon agonist, we show that the endosomal protein Vps37a uncouples glucose production from lipid usage downstream of Gcgr signaling by altering intracellular receptor localization. Hepatocyte-specific knockdown of Vps37a causes an accumulation of Gcgr in endosomes, resulting in overactivation of the cAMP/PKA/p-Creb signaling pathway to gluconeogen-esis without affecting b-oxidation. Shifting the receptor back to the plasma membrane rescues the differen-tial signaling and highlights the importance of the spatiotemporal localization of Gcgr for its metabolic ef-fects. Importantly, since Vps37a knockdown in animals fed with a high-fat diet leads to hyperglycemia, although its overexpression reduces blood glucose levels, these data reveal a contribution of endosomal signaling to metabolic diseases that could be exploited for treatments of type 2 diabetes.
Dokumententyp: | Zeitschriftenartikel |
---|---|
Fakultät: | Medizin > Adolf-Butenandt-Institut
Medizin > Munich Cluster for Systems Neurology (SyNergy) |
Themengebiete: | 600 Technik, Medizin, angewandte Wissenschaften > 610 Medizin und Gesundheit |
URN: | urn:nbn:de:bvb:19-epub-111481-4 |
ISSN: | 1550-4131 |
Sprache: | Englisch |
Dokumenten ID: | 111481 |
Datum der Veröffentlichung auf Open Access LMU: | 02. Apr. 2024, 07:26 |
Letzte Änderungen: | 07. Jun. 2024, 13:51 |
DFG: | Gefördert durch die Deutsche Forschungsgemeinschaft (DFG) - 239283807 |
DFG: | Gefördert durch die Deutsche Forschungsgemeinschaft (DFG) - 390857198 |
DFG: | Gefördert durch die Deutsche Forschungsgemeinschaft (DFG) - 259130777 |
DFG: | Gefördert durch die Deutsche Forschungsgemeinschaft (DFG) - 450149205 |